Page last updated: 2024-10-26

pentetic acid and Bone Loss, Osteoclastic

pentetic acid has been researched along with Bone Loss, Osteoclastic in 2 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jevtic, V1
Watt, I1
Rozman, B1
Presetnik, M1
Logar, D1
Praprotnik, S1
Tomsic, M1
Sipek, A1
Kos-Golja, M1
Sepe, A1
Jarh, O1
Demsar, F1
Musikic, P1
Campion, G1
James, AC1
Taylor, DM1

Trials

1 trial available for pentetic acid and Bone Loss, Osteoclastic

ArticleYear
Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritis.
    British journal of rheumatology, 1996, Volume: 35 Suppl 3

    Topics: Arthritis, Rheumatoid; Bone Resorption; Contrast Media; Double-Blind Method; Female; Gadolinium; Gad

1996

Other Studies

1 other study available for pentetic acid and Bone Loss, Osteoclastic

ArticleYear
DTPA therapy for chelation of 239 Pu in bone: the influence of bone remodelling.
    Health physics, 1971, Volume: 21, Issue:1

    Topics: Alpha Particles; Animals; Autoradiography; Bone and Bones; Bone Neoplasms; Bone Resorption; Epiphyse

1971